MedTrace Logo

Web Based Renal Transplant Patient Medication Education

NCT00327483 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 250

Last updated 2006-05-18

No results posted yet for this study

Summary

Information technology will be brought directly to renal transplant recipients to help them learn about the large number of medications they are required to take on a life long basis, in order to prevent errors and improve safety.

Conditions

  • Renal Transplant Recipients

Interventions

BEHAVIORAL

Internet based education software

Sponsors & Collaborators

  • Agency for Healthcare Research and Quality (AHRQ)

    lead FED

Principal Investigators

  • Amy L Friedman, MD · Yale University

Study Design

Allocation
RANDOMIZED
Purpose
ECT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-07-31
Completion
2006-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00327483 on ClinicalTrials.gov